|
[1]
|
李振国, 林相国, 吕建阳. KLK3基因变异与前列腺癌的相关性分析[J]. 解放军预防医学杂志, 2019, 37(4): 15-16.
|
|
[2]
|
Chen, W., Zheng, R., Baade, P.D., Zhang, S., Zeng, H., Bray, F., et al. (2016) Cancer Statistics in China, 2015. CA: A Cancer Journal for Clinicians, 66, 115-132. [Google Scholar] [CrossRef] [PubMed]
|
|
[3]
|
Chen, R., Sjoberg, D.D., Huang, Y., Xie, L., Zhou, L., He, D., et al. (2017) Prostate Specific Antigen and Prostate Cancer in Chinese Men Undergoing Initial Prostate Biopsies Compared with Western Cohorts. Journal of Urology, 197, 90-96. [Google Scholar] [CrossRef] [PubMed]
|
|
[4]
|
Cao, W., Chen, H., Yu, Y., Li, N. and Chen, W. (2021) Changing Profiles of Cancer Burden Worldwide and in China: A Secondary Analysis of the Global Cancer Statistics 2020. Chinese Medical Journal, 134, 783-791. [Google Scholar] [CrossRef] [PubMed]
|
|
[5]
|
周子滟, 艾子译, 崔丽艳, 等. PSA灰区前列腺癌相关诊断指标的研究进展[J]. 标记免疫分析与临床, 2022, 29(10): 1757-1762.
|
|
[6]
|
Raue, R., Frank, A., Syed, S.N. and Brüne, B. (2021) Therapeutic Targeting of MicroRNAs in the Tumor Microenvironment. International Journal of Molecular Sciences, 22, Article No. 2210. [Google Scholar] [CrossRef] [PubMed]
|
|
[7]
|
黄显莹. MiR-132参与调控动脉粥样硬化过程中的初步研究[D]: [硕士学位论文]. 广州: 南方医科大学, 2016.
|
|
[8]
|
Ameres, S.L. and Zamore, P.D. (2013) Diversifying MicroRNA Sequence and Function. Nature Reviews Molecular Cell Biology, 14, 475-488. [Google Scholar] [CrossRef] [PubMed]
|
|
[9]
|
Khan, S., Ayub, H., Khan, T. and Wahid, F. (2019) MicroRNA Biogenesis, Gene Silencing Mechanisms and Role in Breast, Ovarian and Prostate Cancer. Biochimie, 167, 12-24. [Google Scholar] [CrossRef] [PubMed]
|
|
[10]
|
Loeb, S., Sanda, M.G., Broyles, D.L., Shin, S.S., Bangma, C.H., Wei, J.T., et al. (2015) The Prostate Health Index Selectively Identifies Clinically Significant Prostate Cancer. Journal of Urology, 193, 1163-1169. [Google Scholar] [CrossRef] [PubMed]
|
|
[11]
|
Guazzoni, G., Lazzeri, M., Nava, L., Lughezzani, G., Larcher, A., Scattoni, V., et al. (2012) Preoperative Prostate-Specific Antigen Isoform p2PSA and Its Derivatives, %p2PSA and Prostate Health Index, Predict Pathologic Outcomes in Patients Undergoing Radical Prostatectomy for Prostate Cancer. European Urology, 61, 455-466. [Google Scholar] [CrossRef] [PubMed]
|
|
[12]
|
Mitchell, P.S., Parkin, R.K., Kroh, E.M., Fritz, B.R., Wyman, S.K., Pogosova-Agadjanyan, E.L., et al. (2008) Circulating microRNAs as Stable Blood-Based Markers for Cancer Detection. Proceedings of the National Academy of Sciences, 105, 10513-10518. [Google Scholar] [CrossRef] [PubMed]
|
|
[13]
|
Lodes, M.J., Caraballo, M., Suciu, D., Munro, S., Kumar, A. and Anderson, B. (2009) Detection of Cancer with Serum miRNAs on an Oligonucleotide Microarray. PLOS ONE, 4, e6229. [Google Scholar] [CrossRef] [PubMed]
|
|
[14]
|
赵宇明, 张悦, 王华, 等. miR-135在前列腺癌中的诊断价值研究[J]. 中国实验诊断学, 2018, 22(3): 474-476.
|
|
[15]
|
孟真. microRNA-182和前列腺健康指数对PSA灰区前列腺癌患者的诊断价值研究[D]: [硕士学位论文]. 郑州: 郑州大学, 2020.
|
|
[16]
|
Kadkhoda, S., Eslami, S., Mahmud Hussen, B. and Ghafouri-Fard, S. (2022) A Review on the Importance of miRNA-135 in Human Diseases. Frontiers in Genetics, 13, Article ID: 973585. [Google Scholar] [CrossRef] [PubMed]
|
|
[17]
|
Navarro, A., Diaz, T., Martinez, A., Gaya, A., Pons, A., Gel, B., et al. (2009) Regulation of JAK2 by miR-135a: Prognostic Impact in Classic Hodgkin Lymphoma. Blood, 114, 2945-2951. [Google Scholar] [CrossRef] [PubMed]
|
|
[18]
|
刘润奇, 高学忠, 罗锐娟. miRNA-135a-5p在乳腺癌患者血清中的表达及其临床诊断效能[J]. 癌症进展, 2019, 17(11): 1328-1331.
|
|
[19]
|
李文宏, 曾宪成, 王捷. miRNA-135a在肝癌组织中的表达及临床意义[J]. 岭南现代临床外科, 2017, 17(3): 261-266.
|
|
[20]
|
董大庆. miRNA-135b-5p在结肠癌中表达水平及临床意义[D]: [硕士学位论文]. 承德: 承德医学院, 2019.
|
|
[21]
|
彭扬洋, 邱樊, 王刚. 血清miRNA-135与PSA联合检测对前列腺癌的诊断价值及与临床特征、预后的关系[J]. 癌症进展, 2020, 18(1): 69-72.
|
|
[22]
|
Yamada, Y., Hidaka, H., Seki, N., Yoshino, H., Yamasaki, T., Itesako, T., et al. (2012) Tumor-Suppressive microRNA-135a Inhibits Cancer Cell Proliferation by Targeting the c-MYC Oncogene in Renal Cell Carcinoma. Cancer Science, 104, 304-312. [Google Scholar] [CrossRef] [PubMed]
|
|
[23]
|
赵遵兰, 蔡颖, 王洋洋, 等. 微小RNA-21对人乳腺癌细胞株紫杉醇耐药性的影响及其机制[J]. 浙江大学学报(医学版), 2015, 44(4): 400-409.
|
|
[24]
|
Quaranta, M.T., Olivetta, E., Sanchez, M., Spinello, I., Paolillo, R., Arenaccio, C., et al. (2015) miR-146a Controls CXCR4 Expression in a Pathway That Involves PLZF and Can Be Used to Inhibit HIV-1 Infection of CD4+ T Lymphocytes. Virology, 478, 27-38. [Google Scholar] [CrossRef] [PubMed]
|
|
[25]
|
朱文雄, 袁轶峰, 彭涛, 等. 中西医治疗前列腺癌的研究进展[J]. 湖南中医杂志, 2023, 39(12): 177-181.
|
|
[26]
|
Xu, B., Lu, X., Zhao, Y., Liu, C., Huang, X., Chen, S., et al. (2018) MicroRNA-135a Induces Prostate Cancer Cell Apoptosis via Inhibition of STAT6. Oncology Letters, 17, 1889-1895. [Google Scholar] [CrossRef] [PubMed]
|
|
[27]
|
Li, B., Cao, Y., Sun, M. and Feng, H. (2021) Expression, Regulation, and Function of Exosome-Derived miRNAs in Cancer Progression and Therapy. The FASEB Journal, 35, e21916. [Google Scholar] [CrossRef] [PubMed]
|
|
[28]
|
Gao, Y., Feng, B., Han, S., Zhang, K., Chen, J., Li, C., et al. (2016) The Roles of MicroRNA-141 in Human Cancers: From Diagnosis to Treatment. Cellular Physiology and Biochemistry, 38, 427-448. [Google Scholar] [CrossRef] [PubMed]
|
|
[29]
|
Nakada, C., Matsuura, K., Tsukamoto, Y., Tanigawa, M., Yoshimoto, T., Narimatsu, T., et al. (2008) Genome-Wide microRNA Expression Profiling in Renal Cell Carcinoma: Significant Down-Regulation of miR-141 and miR-200c. The Journal of Pathology, 216, 418-427. [Google Scholar] [CrossRef] [PubMed]
|
|
[30]
|
朱正纲. 我国胃癌外科2017年热点回顾与未来展望[J]. 中华胃肠外科杂志, 2018, 21(1): 7-14.
|
|
[31]
|
王学林, 刘逸翔. 老年肺癌患者血清miR-200b和miR-141表达及对预后的影响[J]. 广东医学, 2019, 40(21): 3040-3044.
|
|
[32]
|
Kim, J., Ryu, J.K., Lee, S.H. and Kim, Y. (2016) MicroRNA 141 Expression Is a Potential Prognostic Marker of Biliary Tract Cancers. Gut and Liver, 10, 836-841. [Google Scholar] [CrossRef] [PubMed]
|
|
[33]
|
Zhou, H., Tang, K., Xiao, H., Zeng, J., Guan, W., Guo, X., et al. (2015) A Panel of Eight-miRNA Signature as a Potential Biomarker for Predicting Survival in Bladder Cancer. Journal of Experimental & Clinical Cancer Research, 34, Article No. 53. [Google Scholar] [CrossRef] [PubMed]
|
|
[34]
|
Zhang, L., Deng, T., Li, X., Liu, H., Zhou, H., Ma, J., et al. (2010) microRNA-141 Is Involved in a Nasopharyngeal Carcinoma-Related Genes Network. Carcinogenesis, 31, 559-566. [Google Scholar] [CrossRef] [PubMed]
|
|
[35]
|
Sun, Y., Liu, Y., Cogdell, D., Calin, G.A., Sun, B., Kopetz, S., et al. (2016) Examining Plasma microRNA Markers for Colorectal Cancer at Different Stages. Oncotarget, 7, 11434-11449. [Google Scholar] [CrossRef] [PubMed]
|
|
[36]
|
Mei, Z., He, Y., Feng, J., Shi, J., Du, Y., Qian, L., et al. (2014) MicroRNA-141 Promotes the Proliferation of Non-Small Cell Lung Cancer Cells by Regulating Expression of PHLPP1 and PHLPP2. FEBS Letters, 588, 3055-3061. [Google Scholar] [CrossRef] [PubMed]
|
|
[37]
|
Zhou, X., Wang, Y., Shan, B., Han, J., Zhu, H., Lv, Y., et al. (2014) The Downregulation of miR-200c/141 Promotes ZEB1/2 Expression and Gastric Cancer Progression. Medical Oncology, 32, Article No. 428. [Google Scholar] [CrossRef] [PubMed]
|
|
[38]
|
Madhavan, D., Peng, C., Wallwiener, M., Zucknick, M., Nees, J., Schott, S., et al. (2016) Circulating miRNAs with Prognostic Value in Metastatic Breast Cancer and for Early Detection of Metastasis. Carcinogenesis, 37, 461-470. [Google Scholar] [CrossRef] [PubMed]
|
|
[39]
|
Wu, S., Ai, H., Zhang, D., Han, X., Pan, Q., Luo, F., et al. (2014) MiR-141 Targets ZEB2 to Suppress HCC Progression. Tumor Biology, 35, 9993-9997. [Google Scholar] [CrossRef] [PubMed]
|
|
[40]
|
Zhao, G., Wang, B., Liu, Y., Zhang, J., Deng, S., Qin, Q., et al. (2013) miRNA-141, Downregulated in Pancreatic Cancer, Inhibits Cell Proliferation and Invasion by Directly Targeting MAP4K4. Molecular Cancer Therapeutics, 12, 2569-2580. [Google Scholar] [CrossRef] [PubMed]
|
|
[41]
|
Brase, J.C., Johannes, M., Schlomm, T., Fälth, M., Haese, A., Steuber, T., et al. (2010) Circulating miRNAs Are Correlated with Tumor Progression in Prostate Cancer. International Journal of Cancer, 128, 608-616. [Google Scholar] [CrossRef] [PubMed]
|
|
[42]
|
竺展坤. 循环miRNAs在前列腺患者血清中的表达水平及临床意义[D]: [硕士学位论文]. 武汉: 武汉工程大学, 2015.
|
|
[43]
|
Liu, C., Liu, R., Zhang, D., Deng, Q., Liu, B., Chao, H., et al. (2017) MicroRNA-141 Suppresses Prostate Cancer Stem Cells and Metastasis by Targeting a Cohort of Pro-Metastasis Genes. Nature Communications, 8, Article No. 14270. [Google Scholar] [CrossRef] [PubMed]
|
|
[44]
|
宁博, 纪宏伟, 陈雪磊. miRNA141表达的调控对人前列腺癌DU145细胞恶性生物行为的影响[J]. 中国肿瘤生物治疗杂志, 2020, 27(9): 999-1005.
|
|
[45]
|
Du, Y., Xu, Y., Ding, L., Yao, H., Yu, H., Zhou, T., et al. (2009) Down-Regulation of miR-141 in Gastric Cancer and Its Involvement in Cell Growth. Journal of Gastroenterology, 44, 556-561. [Google Scholar] [CrossRef] [PubMed]
|
|
[46]
|
Gao, Y. and Wu, J. (2015) microRNA-200c and microRNA-141 as Potential Diagnostic and Prognostic Biomarkers for Ovarian Cancer. Tumor Biology, 36, 4843-4850. [Google Scholar] [CrossRef] [PubMed]
|
|
[47]
|
Manoj, A., Ahmad, M.K., Prasad, G., Kumar, D., Mahdi, A.A. and Kumar, M. (2023) Screening and Validation of Novel Serum Panel of microRNA in Stratification of Prostate Cancer. Prostate International, 11, 150-158. [Google Scholar] [CrossRef] [PubMed]
|
|
[48]
|
廖于峰, 戴金华, 茅奇峰, 等. 循环miRNA-141对前列腺癌的诊断和预后价值研究[J]. 中国病理生理杂志, 2014, 30(10): 1887-1890.
|
|
[49]
|
Osipov, I.D., Zaporozhchenko, I.A., Bondar, A.A., Zaripov, M.M., Voytsitskiy, V.E., Vlassov, V.V., et al. (2016) Cell-Free miRNA-141 and miRNA-205 as Prostate Cancer Biomarkers. In: Gahan, P.B., Fleischhacker, M. and Schmidt, B., Eds., Circulating Nucleic Acids in Serum and Plasma—CNAPS IX, Springer International Publishing, Berlin, 9-12. [Google Scholar] [CrossRef] [PubMed]
|
|
[50]
|
Ye, Y., Yuan, X., Wang, J., Wang, Y. and Li, S. (2020) The Diagnostic Value of miRNA-141 in Prostate Cancer: A Systematic Review and PRISMA-Compliant Meta-Analysis. Medicine, 99, e19993. [Google Scholar] [CrossRef] [PubMed]
|
|
[51]
|
Bryant, R.J., Pawlowski, T., Catto, J.W.F., Marsden, G., Vessella, R.L., Rhees, B., et al. (2012) Changes in Circulating microRNA Levels Associated with Prostate Cancer. British Journal of Cancer, 106, 768-774. [Google Scholar] [CrossRef] [PubMed]
|
|
[52]
|
Yaman Agaoglu, F., Kovancilar, M., Dizdar, Y., Darendeliler, E., Holdenrieder, S., Dalay, N., et al. (2011) Investigation of miR-21, miR-141, and miR-221 in Blood Circulation of Patients with Prostate Cancer. Tumor Biology, 32, 583-588. [Google Scholar] [CrossRef] [PubMed]
|
|
[53]
|
Selth, L.A., Townley, S., Gillis, J.L., Ochnik, A.M., Murti, K., Macfarlane, R.J., et al. (2011) Discovery of Circulating microRNAs Associated with Human Prostate Cancer Using a Mouse Model of Disease. International Journal of Cancer, 131, 652-661. [Google Scholar] [CrossRef] [PubMed]
|
|
[54]
|
Zhang, H., Qin, X., Cao, D., Zhu, Y., Yao, X., Zhang, S., et al. (2013) An Elevated Serum miR-141 Level in Patients with Bone-Metastatic Prostate Cancer Is Correlated with More Bone Lesions. Asian Journal of Andrology, 15, 231-235. [Google Scholar] [CrossRef] [PubMed]
|
|
[55]
|
Zedan, A.H., Osther, P.J.S., Assenholt, J., Madsen, J.S. and Hansen, T.F. (2020) Circulating miR-141 and miR-375 Are Associated with Treatment Outcome in Metastatic Castration Resistant Prostate Cancer. Scientific Reports, 10, Article No. 227. [Google Scholar] [CrossRef] [PubMed]
|
|
[56]
|
Köken, T., Çat, A. and Karalar, M. (2017) Prostate Cancer Detection in Patients with Total Serum Prostate-Specific Antigen Levels of 4-10 ng/ml: Diagnostic Efficacy of MicroRNA-141. Clinical Cancer Investigation Journal, 6, 10-14. [Google Scholar] [CrossRef]
|
|
[57]
|
Hao, Y., Zhao, Y., Zhao, X., He, C., Pang, X., Wu, T., et al. (2011) Improvement of Prostate Cancer Detection by Integrating the PSA Test with miRNA Expression Profiling. Cancer Investigation, 29, 318-324. [Google Scholar] [CrossRef] [PubMed]
|
|
[58]
|
Kachakova, D., Mitkova, A., Popov, E., Popov, I., Vlahova, A., Dikov, T., et al. (2015) Combinations of Serum Prostate-Specific Antigen and Plasma Expression Levels of Let-7c, miR-30c, miR-141, and miR-375 as Potential Better Diagnostic Biomarkers for Prostate Cancer. DNA and Cell Biology, 34, 189-200. [Google Scholar] [CrossRef] [PubMed]
|
|
[59]
|
高自颖, 甄拴平. 血清总前列腺特异性抗原表达的随龄变化及其在前列腺癌鉴别诊断中的意义[J]. 肿瘤研究与临床, 2017, 29(1): 39-41.
|
|
[60]
|
Schröder, F.H., Hugosson, J., Roobol, M.J., et al. (2014) Screening and Prostate Cancer Mortality: Results of the European Randomised Study of Screening for Prostate Cancer (ERSPC) at 13 Years of Follow-Up. The Lancet, 384, 2027-2035.
|
|
[61]
|
Fenton, J.J., Weyrich, M.S., Durbin, S., Liu, Y., Bang, H. and Melnikow, J. (2018) Prostate-Specific Antigen-Based Screening for Prostate Cancer: Evidence Report and Systematic Review for the US Preventive Services Task Force. JAMA, 319, 1914-1931. [Google Scholar] [CrossRef] [PubMed]
|
|
[62]
|
Lojanapiwat, B., Anutrakulchai, W., Chongruksut, W. and Udomphot, C. (2014) Correlation and Diagnostic Performance of the Prostate-Specific Antigen Level with the Diagnosis, Aggressiveness, and Bone Metastasis of Prostate Cancer in Clinical Practice. Prostate International, 2, 133-139. [Google Scholar] [CrossRef] [PubMed]
|
|
[63]
|
Fleshner, K., Carlsson, S.V. and Roobol, M.J. (2016) The Effect of the USPSTF PSA Screening Recommendation on Prostate Cancer Incidence Patterns in the USA. Nature Reviews Urology, 14, 26-37. [Google Scholar] [CrossRef] [PubMed]
|
|
[64]
|
Chistiakov, D.A., Myasoedova, V.A., Grechko, A.V., Melnichenko, A.A. and Orekhov, A.N. (2018) New Biomarkers for Diagnosis and Prognosis of Localized Prostate Cancer. Seminars in Cancer Biology, 52, 9-16. [Google Scholar] [CrossRef] [PubMed]
|
|
[65]
|
Vychytilova-Faltejskova, P., Radova, L., Sachlova, M., Kosarova, Z., Slaba, K., Fabian, P., et al. (2016) Serum-Based microRNA Signatures in Early Diagnosis and Prognosis Prediction of Colon Cancer. Carcinogenesis, 37, 941-950. [Google Scholar] [CrossRef] [PubMed]
|
|
[66]
|
Wach, S., Nolte, E., Szczyrba, J., Stöhr, R., Hartmann, A., Ørntoft, T., et al. (2011) MicroRNA Profiles of Prostate Carcinoma Detected by Multiplatform MicroRNA Screening. International Journal of Cancer, 130, 611-621. [Google Scholar] [CrossRef] [PubMed]
|
|
[67]
|
Chen, Z., Zhang, G., Li, H., Luo, J., Li, Z., Chen, G., et al. (2012) A Panel of Five Circulating microRNAs as Potential Biomarkers for Prostate Cancer. The Prostate, 72, 1443-1452. [Google Scholar] [CrossRef] [PubMed]
|
|
[68]
|
Haldrup, C., Kosaka, N., Ochiya, T., Borre, M., Høyer, S., Orntoft, T.F., et al. (2013) Profiling of Circulating microRNAs for Prostate Cancer Biomarker Discovery. Drug Delivery and Translational Research, 4, 19-30. [Google Scholar] [CrossRef] [PubMed]
|